Clinical Trial Update: Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cyclosporine in combination with carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma expressing high…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Phase 1 | Status: COMPLETED